These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 26232393)

  • 21. Risk factors and outcome of expanded-criteria donor kidney transplants in patients with low immunological risk.
    Praehauser C; Hirt-Minkowski P; Saydam Bakar K; Amico P; Vogler E; Schaub S; Mayr M
    Swiss Med Wkly; 2013; 143():w13883. PubMed ID: 24222631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of survival outcomes between Expanded Criteria Donor and Standard Criteria Donor kidney transplant recipients: a systematic review and meta-analysis.
    Querard AH; Foucher Y; Combescure C; Dantan E; Larmet D; Lorent M; Pouteau LM; Giral M; Gillaizeau F
    Transpl Int; 2016 Apr; 29(4):403-15. PubMed ID: 26756928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preformed Donor-Specific HLA Antibodies in Living and Deceased Donor Transplantation: A Multicenter Study.
    Ziemann M; Altermann W; Angert K; Arns W; Bachmann A; Bakchoul T; Banas B; von Borstel A; Budde K; Ditt V; Einecke G; Eisenberger U; Feldkamp T; Görg S; Guthoff M; Habicht A; Hallensleben M; Heinemann FM; Hessler N; Hugo C; Kaufmann M; Kauke T; Koch M; König IR; Kurschat C; Lehmann C; Marget M; Mühlfeld A; Nitschke M; Pego da Silva L; Quick C; Rahmel A; Rath T; Reinke P; Renders L; Sommer F; Spriewald B; Staeck O; Stippel D; Süsal C; Thiele B; Zecher D; Lachmann N
    Clin J Am Soc Nephrol; 2019 Jul; 14(7):1056-1066. PubMed ID: 31213508
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expanded criteria donor kidneys for retransplantation United Network for Organ Sharing update: proceed with caution.
    Panchal H; Muskovich J; Patterson J; Schroder PM; Ortiz J
    Transpl Int; 2015 Aug; 28(8):990-9. PubMed ID: 25864733
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antibody-Mediated Rejection Due to Preexisting versus
    Aubert O; Loupy A; Hidalgo L; Duong van Huyen JP; Higgins S; Viglietti D; Jouven X; Glotz D; Legendre C; Lefaucheur C; Halloran PF
    J Am Soc Nephrol; 2017 Jun; 28(6):1912-1923. PubMed ID: 28255002
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pre-transplant HLA Antibodies and Delayed Graft Function in the Current Era of Kidney Transplantation.
    Morath C; Döhler B; Kälble F; Pego da Silva L; Echterdiek F; Schwenger V; Živčić-Ćosić S; Katalinić N; Kuypers D; Benöhr P; Haubitz M; Ziemann M; Nitschke M; Emmerich F; Pisarski P; Karakizlis H; Weimer R; Ruhenstroth A; Scherer S; Tran TH; Mehrabi A; Zeier M; Süsal C
    Front Immunol; 2020; 11():1886. PubMed ID: 32983110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term impact of human leukocyte antigen mismatches combined with expanded criteria donor on allograft outcomes in deceased donor kidney transplantation.
    Shin S; Kim YH; Choi BH; Choi JY; Jung JH; Cho HK; Han DJ
    Clin Transplant; 2015 Jan; 29(1):44-51. PubMed ID: 25382387
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pediatric en bloc kidney transplantation to adult recipients: more than suboptimal?
    Bhayana S; Kuo YF; Madan P; Mandaym S; Thomas PG; Lappin JA; Rice JC; Ishihara K
    Transplantation; 2010 Aug; 90(3):248-54. PubMed ID: 20548262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidemiology of Kidney Discard from Expanded Criteria Donors Undergoing Donation after Circulatory Death.
    Singh SK; Kim SJ
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):317-23. PubMed ID: 26668028
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Donor-specific anti-HLA antibodies with antibody-mediated rejection and long-term outcomes following heart transplantation.
    Clerkin KJ; Farr MA; Restaino SW; Zorn E; Latif F; Vasilescu ER; Marboe CC; Colombo PC; Mancini DM
    J Heart Lung Transplant; 2017 May; 36(5):540-545. PubMed ID: 27916323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the current post-transplantation Human Leukocyte Antigen antibody screening in pediatric renal transplant recipients.
    Demirok A; Ranzijn C; Lardy J; Florquin S; Bouts A
    Pediatr Transplant; 2019 Mar; 23(2):e13338. PubMed ID: 30635959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Intermediate-term outcomes with expanded criteria deceased donors in kidney transplantation: a spectrum or specter of quality?
    Stratta RJ; Rohr MS; Sundberg AK; Farney AC; Hartmann EL; Moore PS; Rogers J; Iskandar SS; Gautreaux MD; Kiger DF; Doares W; Anderson TK; Hairston G; Adams PL
    Ann Surg; 2006 May; 243(5):594-601; discussion 601-3. PubMed ID: 16632993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics and Performance of Unilateral Kidney Transplants from Deceased Donors.
    Husain SA; Chiles MC; Lee S; Pastan SO; Patzer RE; Tanriover B; Ratner LE; Mohan S
    Clin J Am Soc Nephrol; 2018 Jan; 13(1):118-127. PubMed ID: 29217537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Donor Specificity but Not Broadness of Sensitization Is Associated With Antibody-Mediated Rejection and Graft Loss in Renal Allograft Recipients.
    Wehmeier C; Hönger G; Cun H; Amico P; Hirt-Minkowski P; Georgalis A; Hopfer H; Dickenmann M; Steiger J; Schaub S
    Am J Transplant; 2017 Aug; 17(8):2092-2102. PubMed ID: 28245084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Preformed donor-specific antibodies and risk of antibody-mediated rejection in repeat renal transplantation.
    Tsapepas DS; Vasilescu R; Tanriover B; Coppleson Y; Rekhtman Y; Hardy MA; Dube G; Crew RJ; Ratner LE; Cohen DJ; Mohan S
    Transplantation; 2014 Mar; 97(6):642-7. PubMed ID: 24637863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Improve in-depth immunological risk assessment to optimize genetic-compatibility and clinical outcomes in child and adolescent recipients of parental donor kidney transplants: protocol for the INCEPTION study.
    Lim WH; Adams B; Alexander S; Bouts AHM; Claas F; Collins M; Cornelissen E; Dunckley H; de Jong H; D'Orsogna L; Francis A; Heidt S; Herman J; Holdsworth R; Kausman J; Khalid R; Kim JJ; Kim S; Knops N; Kosmoliaptsis V; Kramer C; Kuypers D; Larkins N; Palmer SC; Prestidge C; Prytula A; Sharma A; Shingde M; Taverniti A; Teixeira-Pinto A; Trnka P; Willis F; Wong D; Wong G
    BMC Nephrol; 2021 Dec; 22(1):416. PubMed ID: 34923958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eplet mismatch analysis and allograft outcome across racially diverse groups in a pediatric transplant cohort: a single-center analysis.
    Philogene MC; Amin A; Zhou S; Charnaya O; Vega R; Desai N; Neu AM; Pruette CS
    Pediatr Nephrol; 2020 Jan; 35(1):83-94. PubMed ID: 31599339
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circulating donor-specific anti-HLA antibodies are a major factor in premature and accelerated allograft fibrosis.
    Gosset C; Viglietti D; Rabant M; Vérine J; Aubert O; Glotz D; Legendre C; Taupin JL; Duong Van-Huyen JP; Loupy A; Lefaucheur C
    Kidney Int; 2017 Sep; 92(3):729-742. PubMed ID: 28554738
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Assessment of kidneys procured from expanded criteria donors before transplantation.
    Domagala P; Kwiatkowski A; Perkowska-Ptasinska A; Wszola M; Panufnik L; Paczek L; Durlik M; Chmura A
    Transplant Proc; 2009 Oct; 41(8):2966-9. PubMed ID: 19857651
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes and Discard Rate of Kidneys by Decade of Extended Criteria Donor Age.
    Messina M; Diena D; Dellepiane S; Guzzo G; Lo Sardo L; Fop F; Segoloni GP; Amoroso A; Magistroni P; Biancone L
    Clin J Am Soc Nephrol; 2017 Feb; 12(2):323-331. PubMed ID: 27979977
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.